leadf
logo-loader
viewTetra Bio-Pharma

Tetra Bio-Pharma adds two experienced life sciences execs to its board, new.COO to management team

Tetra Bio-Pharma Inc. (TSX:TBP.TO) (OTCQB:TBPMF) Chairman of the Board Bill Cheliak tells Proactive the Ottawa-based group has added two new board members and has appointed a new COO. Cheliak says board members Dale Weil and Dr. Brent Norton, along with COO Dr. Graham Wood will be key to helping to advance many of the firm's clinical assets to commercialization.

Quick facts: Tetra Bio-Pharma

Price: - -

TSX-V:TBP
Market: TSX-V
Market Cap: -
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Tetra Bio-Pharma named herein, including the promotion by the Company of Tetra Bio-Pharma in any Content on the Site, the Company receives from...

FOR OUR FULL DISCLAIMER CLICK HERE

Tetra Bio-Pharma acquires Canadian rights to Dronabinol Soft Gel capsules,...

Tetra Bio-Pharma Inc. (TSX:TBP) (OTCQB:TBPMF) Chief Commercial Officer Steeve Néron tells Proactive the biotech has acquired the Canadian exclusive rights for Dronabinol Soft Gel capsules, cannabinoid derived prescription drug aimed to treat AIDS-related anorexia and severe nausea and vomiting...

3 weeks, 1 day ago

2 min read